Parlodel® (bromocriptine mesylate) capsules, USP 5 mg

DRUG2 trials

Sponsors

Mylan Pharmaceuticals Inc

Conditions

Healthy

Phase 1

Fed Study of (Parlodel®) 2.5 mg Bromocriptine Mesylate Tablets

CompletedNCT00650520

Mylan Pharmaceuticals IncHealthy

Start: 2007-05-31End: 2007-07-31Updated: 2024-04-24

Fed Study of (Parlodel®) Bromocriptine Mesylate Capsules 5 mg

CompletedNCT00649168

Mylan Pharmaceuticals IncHealthy

Start: 2007-04-30End: 2007-06-30Updated: 2024-04-24